XML 49 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (354) $ (1,560)
Adjustments to reconcile net loss to net cash provided by operations:    
Depreciation and amortization 2,060 2,234
Provision for doubtful accounts 20 27
Share-based compensation 131 113
Amortization of original issue discount (OID) 64 403
Gain on settlement of note payable and litigation (1,034) 0
(Gain) loss on sale/disposal of assets 0 (72)
Interest income on settlement 0 (48)
Discount on early payoff of Legiant Notes 0 (135)
Loss on debt refinancing 1,402 0
Changes in operating assets and liabilities:    
Restricted cash 400 (150)
Accounts receivable 182 (672)
Inventory (241) 84
Prepaid expenses and other assets (122) 196
Accounts payable 28 (967)
Accrued expenses and other long-term obligations 150 658
Deferred revenue (1,015) 1,058
Net cash provided by operating activities 1,671 1,169
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisitions net of cash acquired (3,111) 0
Net purchases of property and equipment (347) (143)
Collection of note receivable 9 10
Net cash used in investing activities (3,449) (133)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments on notes payable (17,723) (5,707)
Proceeds from notes payable 18,179 2,500
Payments on amendment of senior notes payable (704) 0
Net proceeds from issuance of common stock 0 3,435
Debt financing fees (565) (298)
Insurance proceeds for settlement of notes payable dispute, net of expenses 373 0
Payments on capital leases (104) (64)
Net proceeds from exercise of options 24 13
Net cash used in financing activities (520) (121)
Effect of translation exchange rates (3) 14
Net increase (decrease) in cash and cash equivalents (2,301) 929
Cash and equivalents at beginning of period 3,938 2,177
Cash and equivalents at end of period 1,637 3,106
SUPPLEMENTAL INFORMATION:    
Interest 937 361
Non-cash Investing and Financing Activities:    
Conversion of subordinated convertible notes payable to equity 249 0
Accrued contingent consideration upon acquisition $ 327 $ 0